Patents by Inventor Carsten Denmark Andersen

Carsten Denmark Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090142803
    Abstract: The inventors have discovered some striking, and not previously predicted structural similarities and differences between the structure of Novamyl and the reported structures of CGTases, and based on this they have constructed variants of maltogenic alpha-amylase having CGTase activity and variants of CGTase having maltogenic alpha-amylase activity. Further, on the basis of sequence homology between Novamyl® and CGTases, the inventors have constructed hybrid enzymes with one or more improvements to specific properties of the parent enzymes, using recombinant DNA methodology.
    Type: Application
    Filed: September 11, 2008
    Publication date: June 4, 2009
    Applicant: Novozymes A/S
    Inventors: Joel Robert Cherry, Allan Svendsen, Carsten Denmark Andersen, Lars Beier, Torben Peter Frandsen, Thomas Schafer
  • Publication number: 20030215928
    Abstract: The inventors have discovered some striking, and not previously predicted structural similarities and differences between the structure of Novamyl and the reported structures of CGTases, and based on this they have constructed variants of maltogenic alpha-amylase having CGTase activity and variants of CGTase having maltogenic alpha-amylase activity. Further, on the basis of sequence homology between Novamyl and CGTases, the inventors have constructed hybrid enzymes with one or more improvements to specific properties of the parent enzymes, using recombinant DNA methodology.
    Type: Application
    Filed: May 29, 2003
    Publication date: November 20, 2003
    Applicant: Novozymes A/S
    Inventors: Joel Robert Cherry, Allan Svendsen, Carsten Denmark Andersen, Lars Beier, Torben Peter Frandsen, Thomas Schafer
  • Publication number: 20030059902
    Abstract: The inventors have discovered some striking, and not previously predicted structural similarities and differences between the structure of Novamyl and the reported structures of CGTases, and based on this they have constructed variants of maltogenic alpha-amylase having CGTase activity and variants of CGTase having maltogenic alpha-amylase activity. Further, on the basis of sequence homology between Novamyl® and CGTases, the inventors have constructed hybrid enzymes with one or more improvements to specific properties of the parent enzymes, using recombinant DNA methodology.
    Type: Application
    Filed: September 4, 2002
    Publication date: March 27, 2003
    Applicant: Novozymes A/S
    Inventors: Joel Robert Cherry, Allan Svendsen, Carsten Denmark Andersen, Lars Beier, Torben Peter Frandsen, Thomas Schafer
  • Patent number: 6482622
    Abstract: The inventors have discovered some striking, and not previously predicted structural similarities and differences between the structure of Novamyl and the reported structures of CGTases, and based on this they have constructed variants of maltogenic alpha-amylase having CGTase activity and variants of CGTase having maltogenic alpha-amylase activity. Further, on the basis of sequence homology between Novamyl® and CGTases, the inventors have constructed hybrid enzymes with one or more improvements to specific properties of the parent enzymes, using recombinant DNA methodology.
    Type: Grant
    Filed: August 24, 2000
    Date of Patent: November 19, 2002
    Assignee: Novozymes A/S
    Inventors: Joel Robert Cherry, Allan Svendsen, Carsten Denmark Andersen, Lars Beier, Torben Peter Frandsen, Thomas Schäfer